{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T20:51:06Z","timestamp":1790542266073,"version":"4.1.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2003,2,14]],"date-time":"2003-02-14T00:00:00Z","timestamp":1045180800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2003,5]]},"DOI":"10.1007\/s00345-002-0316-x","type":"journal-article","created":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T22:16:54Z","timestamp":1576102614000},"page":"31-36","source":"Crossref","is-referenced-by-count":46,"title":["Antiestrogens and selective estrogen receptor modulators reduce prostate cancer risk"],"prefix":"10.1007","volume":"21","author":[{"given":"Mitchell S.","family":"Steiner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharan","family":"Raghow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2003,2,14]]},"reference":[{"key":"0316_CR1","first-page":"861","volume":"69","author":"Arai","year":"1978","unstructured":"Arai Y, Chen CY, Nishizuka Y (1978) Cancer development in male reproductive tract in rats given diethylstilbestrol at neonatal age. Gann 69:861\u2013862","journal-title":"Gann"},{"key":"0316_CR2","first-page":"743","volume":"7","author":"Aronica","year":"1993","unstructured":"Aronica SM, Katzenellenbogen BS (1993) Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-I. Mol Endocrinol 7:743\u2013752","journal-title":"Mol Endocrinol"},{"key":"0316_CR3","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/0024-3205(80)90049-1","volume":"26","author":"Black","year":"1980","unstructured":"Black LJ, Goode RL (1980) Uterine bioassay of tamoxifen, trioxifene and a new estrogen antagonist (LY117018) in rats and mice. Life Sci 26:1453\u20131458","journal-title":"Life Sci"},{"key":"0316_CR4","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0960-0760(98)00056-9","volume":"66","author":"Blanchere","year":"1998","unstructured":"Blanchere M, Berthaut I, Portois MC, Mestayer C, Mowszowicz I (1998) Hormonal regulation of the androgen receptor expression in human prostatic cells in culture. J Steroid Biochem Mol Biol 66:319\u2013326","journal-title":"J Steroid Biochem Mol Biol"},{"key":"0316_CR5","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1080\/003655999750015844","volume":"33","author":"Bodker","year":"1999","unstructured":"Bodker A, Bruun J, Balslev E, Iversen HG, Meyhoff HH, Andersson KE (1999) Estrogen receptors in the human male prostatic urethra and prostate in prostatic cancer and benign prostatic hyperplasia. Scand J Urol Nephrol 33:237\u2013242","journal-title":"Scand J Urol Nephrol"},{"key":"0316_CR6","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0002-9440(10)65160-7","volume":"155","author":"Bonkhoff","year":"1999","unstructured":"Bonkhoff H, Fixemer T, Hunsicker I, Remberger K (1999) Estrogen receptor expression in prostate cancer and premalignant prostatic lesions. Am J Pathol 155:641\u2013647","journal-title":"Am J Pathol"},{"key":"0316_CR7","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/pros.2990200404","volume":"20","author":"Brolin","year":"1992","unstructured":"Brolin J, Skoog L, Ekman P (1992) Immunohistochemistry and biochemistry in detection of androgen, progesterone, and estrogen receptors in benign and malignant human prostatic tissue. Prostate 20:281\u2013295","journal-title":"Prostate"},{"key":"0316_CR8","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/bjc.1988.248","volume":"58","author":"Bruning","year":"1988","unstructured":"Bruning P, Bonfrer J, Hart A (1988) Tamoxifen, serum lipoproteins and cardiovascular risk. Br J Cancer 58:497\u2013499","journal-title":"Br J Cancer"},{"key":"0316_CR9","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0890-6238(98)00003-3","volume":"12","author":"Buelke-Sam","year":"1998","unstructured":"Buelke-Sam J, Bryant HU, Francis PC (1998) The selective estrogen receptor modulator, raloxifene: an overview of nonclinical pharmacology and reproductive and developmental testing. Reprod Toxicol 12:217\u2013221","journal-title":"Reprod Toxicol"},{"key":"0316_CR10","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1210\/endo.136.5.7536668","volume":"136","author":"Castagnetta","year":"1995","unstructured":"Castagnetta LA, Miceli MD, Sorci CM, Pfeffer U, Farruggio R, Oliveri G, Calabro M, Carruba G (1995) Growth of LNCaP human prostate cancer cells is stimulated by estradiol via its own receptor. Endocrinology 136:2309\u20132319","journal-title":"Endocrinology"},{"key":"0316_CR11","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0094-0143(02)00019-8","volume":"29","author":"Castle","year":"2002","unstructured":"Castle EP, Thrasher JB (2002) The role of soy phytoestrogens in prostate cancer. Urol Clin North Am 29:71\u201381","journal-title":"Urol Clin North Am"},{"key":"0316_CR12","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/(SICI)1097-0045(19990701)40:2<115::AID-PROS7>3.0.CO;2-3","volume":"40","author":"Chang","year":"1999","unstructured":"Chang WY, Prins GS (1999) Estrogen receptor-beta: implications for the prostate gland. Prostate 40:115\u2013124","journal-title":"Prostate"},{"key":"0316_CR13","unstructured":"Cheng E, Lee C, Grayhack J (1993) Endocrinology of the prostate. In: Lepor H, Lawson R (eds) Prostate diseases. Saunders, Philadelphia, pp 57\u201371"},{"key":"0316_CR14","doi-asserted-by":"crossref","first-page":"4613","DOI":"10.1210\/endo.138.11.5496","volume":"138","author":"Couse","year":"1997","unstructured":"Couse JF, Lindzey J, Grandien K, Gustafsson JA, Korach KS (1997) Tissue distribution and quantitative analysis of estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse. Endocrinology 138:4613\u20134621","journal-title":"Endocrinology"},{"key":"0316_CR15","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1159\/000019912","volume":"35","author":"Denis","year":"1999","unstructured":"Denis L, Morton MS, Griffiths K (1999) Diet and its preventive role in prostatic disease. Eur Urol 35:377\u2013387","journal-title":"Eur Urol"},{"key":"0316_CR16","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/pros.2990270603","volume":"27","author":"Ehara","year":"1995","unstructured":"Ehara H, Koji T, Deguchi T, Yoshii A, Nakano M, Nakane PK, Kawada Y (1995) Expression of estrogen receptor in diseased human prostate assessed by non-radioactive in situ hybridization and immunohistochemistry. Prostate 27:304\u2013313","journal-title":"Prostate"},{"key":"0316_CR17","first-page":"4258","volume":"82","author":"Enmark","year":"1997","unstructured":"Enmark E, Pelto-Huikko M, Grandien K, Lagercrantz S, Lagercrantz J, Fried G, Nordenskjold M, Gustafsson JA (1997) Human estrogen receptor beta-gene structure, chromosomal localization, and expression pattern. J Clin Endocrinol Metab 82:4258\u20134265","journal-title":"J Clin Endocrinol Metab"},{"key":"0316_CR18","first-page":"4096","volume":"56","author":"Gingrich","year":"1996","unstructured":"Gingrich JR, Barrios RJ, Morton RA, Boyce BF, DeMayo FJ, Finegold MJ, Angelopoulou R, Rosen JM, Greenberg NM (1996) Metastatic prostate cancer in a transgenic mouse. Cancer Res 56:4096\u20134102","journal-title":"Cancer Res"},{"key":"0316_CR19","first-page":"4687","volume":"57","author":"Gingrich","year":"1997","unstructured":"Gingrich JR, Barrios RJ, Kattan MJ, Nahm HS, Finegold MJ, Greenberg NM (1997) Androgen independent prostate cancer progression in the TRAMP model. Cancer Res 57:4687\u20134691","journal-title":"Cancer Res"},{"key":"0316_CR20","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1073\/pnas.92.8.3439","volume":"92","author":"Greenberg","year":"1995","unstructured":"Greenberg NM, DeMayo F, Finegold MJ, Medina D, Tilley WD, Aspinall JO, Cunha GR, Donjacour AA, Matusik RJ, Rosen JM (1995) Prostate cancer in a transgenic mouse. Proc Natl Acad Sci USA 92:3439\u20133443","journal-title":"Proc Natl Acad Sci USA"},{"key":"0316_CR21","unstructured":"Griffiths K, Cockett A, Coffey D, Krieg M, Lee C, McKeehan W, Neal D, Partin A, DiSant'Agnese A, Schalken J (1998) Regulation of prostate growth. 4th International Consultation on BPH, Paris, pp 83\u2013128"},{"key":"0316_CR22","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/pros.2990130406","volume":"13","author":"Habenicht","year":"1988","unstructured":"Habenicht UF, el Etreby MF (1988) The periurethral zone of the prostate of the cynomolgus monkey is the most sensitive prostate part for an estrogenic stimulus. Prostate 13:305\u2013316","journal-title":"Prostate"},{"key":"0316_CR23","first-page":"129","volume":"13","author":"Hanstein","year":"1999","unstructured":"Hanstein B, Liu H, Yancisin MC, Brown M (1999) Functional analysis of a novel estrogen receptor-beta isoform. Mol Endocrinol 13:129\u2013137","journal-title":"Mol Endocrinol"},{"key":"0316_CR24","first-page":"4534","volume":"53","author":"Hard","year":"1993","unstructured":"Hard GC, Iatropoulous MJ, Jordan K (1993) Major difference in the hepatocarcinogenicity and DNA adduct forming ability between toremifene and tamoxifen in female Crl:CD (BR) rats. Cancer Res 53:4534\u20134541","journal-title":"Cancer Res"},{"key":"0316_CR25","unstructured":"Ho S-M, Lee K-F, Lane K (1997) Neoplastic transformation of the prostate. In: Naz R (ed) Prostate basic and clinical aspects. CRC, New York, pp 74\u2013114"},{"key":"0316_CR26","first-page":"1167","volume":"10","author":"Horwitz","year":"1996","unstructured":"Horwitz KB, Jackson TA, Bain DL, Richer JK, Takimoto GS, Tung L (1996) Nuclear receptor coactivators and corepressors. Mol Endocrinol 10:1167\u20131177","journal-title":"Mol Endocrinol"},{"key":"0316_CR27","first-page":"1","volume":"16H","author":"Kelloff","year":"1992","unstructured":"Kelloff GJ, Boone CW, Malone WF, Steele VE, Doody LA (1992) Introductory remarks: Development of chemopreventive agents for prostate cancer. J Cell Biochem Suppl 16H:1\u20138","journal-title":"J Cell Biochem Suppl"},{"key":"0316_CR28","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1159\/000019906","volume":"35","author":"Kelloff","year":"1999","unstructured":"Kelloff GJ, Lieberman R, Steele VE, Boone CW, Lubet RA, Kopelovitch L, Malone WA, Crowell JA, Sigman CC (1999) Chemoprevention of prostate cancer: concepts and strategies. Eur Urol 35:342\u2013350","journal-title":"Eur Urol"},{"key":"0316_CR29","first-page":"5365","volume":"62","author":"Kim","year":"2002","unstructured":"Kim IY, Kim BC, Seong DH, Lee DK, Seo JM, Hong YJ, Kim HT, Morton RA, Kim SJ (2002) Raloxifene, a mixed estrogen agonist\/antagonist, induces apoptosis in androgen-independent human prostate cancer cell lines. Cancer Res 62:5365\u20135369","journal-title":"Cancer Res"},{"key":"0316_CR30","doi-asserted-by":"publisher","first-page":"15677","DOI":"10.1073\/pnas.95.26.15677","volume":"95","author":"Krege","year":"1998","unstructured":"Krege JH, Hodgin JB, Couse JF, Enmark E, Warner M, Mahler JF, Sar M, Korach KS, Gustafsson JA, Smithies O (1998) Generation and reproductive phenotypes of mice lacking estrogen receptor beta. Proc Natl Acad Sci U S A 95:15677\u201315682","journal-title":"Proc Natl Acad Sci U S A"},{"key":"0316_CR31","doi-asserted-by":"publisher","first-page":"5925","DOI":"10.1073\/pnas.93.12.5925","volume":"93","author":"Kuiper","year":"1996","unstructured":"Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA (1996) Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci U S A 93:5925\u20135930","journal-title":"Proc Natl Acad Sci U S A"},{"key":"0316_CR32","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1210\/endo.138.3.4979","volume":"138","author":"Kuiper","year":"1997","unstructured":"Kuiper GG, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S, Gustafsson JA (1997) Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138:863\u2013870","journal-title":"Endocrinology"},{"key":"0316_CR33","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0960-0760(99)00065-5","volume":"69","author":"Labrie","year":"1999","unstructured":"Labrie F, Labrie C, Belanger A, Simard J, Gauthier S, Luu-The V, Merand Y, Giguere V, Candas B, Luo S, Martel C, Singh SM, Fournier M, Coquet A, Richard V, Charbonneau R, Charpenet G, Tremblay A, Tremblay G, Cusan L, Veilleux R (1999) EM-652 (SCH 57068), a third generation SERM acting as pure antiestrogen in the mammary gland and endometrium. J Steroid Biochem Mol Biol 69:51\u201384","journal-title":"J Steroid Biochem Mol Biol"},{"key":"0316_CR34","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0006-291X(84)91062-3","volume":"118","author":"Lam","year":"1984","unstructured":"Lam HY (1984) Tamoxifen is a calmodulin antagonist in the activation of cAMP phosphodiestrase. Biochem Biophys Res Commun 118:27\u201332","journal-title":"Biochem Biophys Res Commun"},{"key":"0316_CR35","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3322\/canjclin.49.1.8","volume":"49","author":"Landis","year":"1999","unstructured":"Landis SH, Murray T, Bolden S, Wingo PA (1999) Cancer statistics, 1999. CA Cancer J Clin 49:8\u201331","journal-title":"CA Cancer J Clin"},{"key":"0316_CR36","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1210\/endo.139.1.5809","volume":"139","author":"Lau","year":"1998","unstructured":"Lau KM, Leav I, Ho SM (1998) Rat estrogen receptor-alpha and -beta, and progesterone receptor mRNA expression in various prostatic lobes and microdissected normal and dysplastic epithelial tissues of the Noble rats. Endocrinology 139:424\u2013427","journal-title":"Endocrinology"},{"key":"0316_CR37","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1093\/jnci\/80.13.1045","volume":"80","author":"Leav","year":"1988","unstructured":"Leav I, Ho SM, Ofner P, Merk FB, Kwan PW, Damassa D (1988) Biochemical alterations in sex hormone-induced hyperplasia and dysplasia of the dorsolateral prostates of Noble rats. J Natl Cancer Inst 80:1045\u20131053","journal-title":"J Natl Cancer Inst"},{"key":"0316_CR38","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/pros.2990150104","volume":"15","author":"Leav","year":"1989","unstructured":"Leav I, Merk FB, Kwan PW, Ho SM (1989) Androgen-supported estrogen-enhanced epithelial proliferation in the prostates of intact Noble rats. Prostate 15:23\u201340","journal-title":"Prostate"},{"key":"0316_CR39","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1056\/NEJM199203263261302","volume":"326","author":"Love","year":"1992","unstructured":"Love RR, Mazees RB, Barden HS (1992) Effect of tamoxifen on bone mineral density in post menopausal women with breast cancer. N Engl J Med 326:852\u2013856","journal-title":"N Engl J Med"},{"key":"0316_CR40","first-page":"5621","volume":"55","author":"Lucia","year":"1995","unstructured":"Lucia MS, Anzano MA, Slatyer MV, Anver MR, Green DM, Shrader MW, Logsdon DL, Driver CL, Brown CC, Peer CW, Roberts AB, Sporn MB (1995) Chemopreventive activity of tamoxifen, N-(4-hydroxyphenyl) retinamide, and the vitamin D analogue Ro24\u20135531 for androgen-promoted carcinomas of the rat seminal vesicle and prostate. Cancer Res 55:5621\u20135627","journal-title":"Cancer Res"},{"key":"0316_CR41","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1136\/bmj.311.7011.977","volume":"311","author":"McDonald","year":"1995","unstructured":"McDonald CC, Alexander FE, Whyte BW (1995) Cardiac and vascular morbidity in women receiving adjuvant tamoxifen for breast cancer in a randomized trial. BMJ 311:977\u2013980","journal-title":"BMJ"},{"key":"0316_CR42","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/0022-4731(83)90151-6","volume":"19","author":"Mobbs","year":"1983","unstructured":"Mobbs BG, Johnson IE, Connolly JG, Thompson J (1983) Concentration and cellular distribution of androgen receptor in human prostatic neoplasia: Can estrogen treatment increase androgen receptor content? J Steroid Biochem 19:1279\u20131290","journal-title":"J Steroid Biochem"},{"key":"0316_CR43","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/pros.2990160307","volume":"16","author":"Mobbs","year":"1990","unstructured":"Mobbs BG, Johnson IE, Liu Y (1990) Quantitation of cytosolic and nuclear estrogen and progesterone receptor in benign, untreated, and treated malignant human prostatic tissue by radioligand binding and enzyme-immunoassays. Prostate 16:235\u2013244","journal-title":"Prostate"},{"key":"0316_CR44","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s002040050068","volume":"68","author":"Montandon","year":"1994","unstructured":"Montandon F, Williams GM (1994) Comparison of DNA reactivity of poly-phenylethylene hormonal agents diethylstilbestrol, tamoxifen and toremifene in rat and hamster liver. Arch Toxicol 68:272\u2013275","journal-title":"Arch Toxicol"},{"key":"0316_CR45","doi-asserted-by":"publisher","first-page":"25443","DOI":"10.1074\/jbc.273.39.25443","volume":"273","author":"Montano","year":"1998","unstructured":"Montano MM, Jaiswal AK, Katzenellenbogen BS (1998) Transcriptional regulation of the human quinone reductase gene by antiestrogen-liganded estrogen receptor-alpha and estrogen receptor-beta. J Biol Chem 273:25443\u201325449","journal-title":"J Biol Chem"},{"key":"0316_CR46","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1172\/JCI109310","volume":"63","author":"Moore","year":"1979","unstructured":"Moore RJ, Gazak JM, Wilson JD (1979) Regulation of cytoplasmic dihydrotestosterone binding in dog prostate by 17\u03b2-estradiol. J Clin Invest 63:351\u2013357","journal-title":"J Clin Invest"},{"key":"0316_CR47","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/0014-5793(96)00782-X","volume":"392","author":"Mosselman","year":"1996","unstructured":"Mosselman S, Polman J, Dijkema R (1996) ER beta: identification and characterization of a novel human estrogen receptor. FEBS Lett 392:49\u201353","journal-title":"FEBS Lett"},{"key":"0316_CR48","first-page":"246","volume":"23","author":"Neubauer","year":"1993","unstructured":"Neubauer BL, Best KL, Clemens JA, Gates CA, Goode RL, Jones CD, Laughlin ME, Shaar CJ, Toomey RE, Hoover DM (1993) Endocrine and antiprostatic effects of raloxifene (LY 156758) in the male rat. Prostate 23:246\u2013262","journal-title":"Prostate"},{"key":"0316_CR49","first-page":"2462","volume":"45","author":"O'Brien","year":"1985","unstructured":"O'Brien CA, Liskamp RM, Solomon DH (1985) Inhibition of protein kinase C by tamoxifen. Cancer Res 45:2462\u20132465","journal-title":"Cancer Res"},{"key":"0316_CR50","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/0041-008X(92)90200-C","volume":"112","author":"Ofner","year":"1992","unstructured":"Ofner P, Bosland MC, Vena RL (1992) Differential effects of diethylstilbestrol and estradiol-17 beta in combination with testosterone on rat prostate lobes. Toxicol Appl Pharmacol 112:300\u2013309","journal-title":"Toxicol Appl Pharmacol"},{"key":"0316_CR51","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1126\/science.277.5331.1508","volume":"277","author":"Paech","year":"1997","unstructured":"Paech K, Webb P, Kuiper GG, Nilsson S, Gustafsson J, Kushner PJ, Scanlan TS (1997) Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science 277:1508\u20131510","journal-title":"Science"},{"key":"0316_CR52","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1210\/endo.139.3.5840","volume":"139","author":"Petersen","year":"1998","unstructured":"Petersen DN, Tkalcevic GT, Koza-Taylor PH, Turi TG, Brown TA (1998) Identification of estrogen receptor beta2, a functional variant of estrogen receptor beta expressed in normal rat tissues. Endocrinol 139:1082\u20131092","journal-title":"Endocrinol"},{"key":"0316_CR53","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1002\/(SICI)1097-0045(19990601)39:4<305::AID-PROS12>3.0.CO;2-Y","volume":"39","author":"Pollard","year":"1999","unstructured":"Pollard M (1999) Prevention of prostate-related cancers in Lobund-Wistar rats. Prostate 39:305\u2013309","journal-title":"Prostate"},{"key":"0316_CR54","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/02652038509373531","volume":"2","author":"Price","year":"1985","unstructured":"Price KR, Fenwick GR (1985) Naturally occurring oestrogens in foods-a review. Food Addit Contam 2:73\u2013106","journal-title":"Food Addit Contam"},{"key":"0316_CR55","unstructured":"Prins G (1997) Developmental estrogenization of the prostate gland. In: Naz R (ed) Prostate basic and clinical aspects. CRC, New York, pp 247\u2013265"},{"key":"0316_CR56","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1210\/endo.139.3.5827","volume":"139","author":"Prins","year":"1998","unstructured":"Prins GS, Marmer M, Woodham C, Chang W, Kuiper G, Gustafsson JA, Birch L (1998) Estrogen receptor-beta messenger ribonucleic acid ontogeny in the prostate of normal and neonatally estrogenized rats. Endocrinology 139:874\u2013883","journal-title":"Endocrinology"},{"key":"0316_CR57","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/S0022-5347(17)36458-3","volume":"149","author":"Pylkkanen","year":"1993","unstructured":"Pylkkanen L, Makela S, Valve E, Harkonen P, Toikkanen S, Santti R (1993) Prostatic dysplasia associated with increased expression of c-myc in neonatally estrogenized mice. J Urol 149:1593\u20131601","journal-title":"J Urol"},{"key":"0316_CR58","first-page":"1370","volume":"62","author":"Raghow","year":"2002","unstructured":"Raghow S, Hooshdaran MZ, Katiyar S, Steiner MS (2002) Toremifene prevents prostate cancer in the transgenic adenocarcinoma of mouse prostate model. Cancer Res 62:1370\u20131376","journal-title":"Cancer Res"},{"key":"0316_CR59","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/(SICI)1097-0045(19980915)37:1<51::AID-PROS8>3.0.CO;2-B","volume":"37","author":"Rohlff","year":"1998","unstructured":"Rohlff C, Blagosklonny MV, Kyle E, Kesari A, Kim IY, Zelner DJ, Hakim F, Trepel J, Bergan RC (1998) Prostate cancer cell growth inhibition by tamoxifen is associated with inhibition of protein kinase C and induction of p21 (waf1\/cip1). Prostate 37:51\u201359","journal-title":"Prostate"},{"key":"0316_CR60","first-page":"45","volume":"76","author":"Ross","year":"1986","unstructured":"Ross R, Bernstein L, Judd H, Hanisch R, Pike M, Henderson B (1986) Serum testosterone levels in healthy young black and white men. J Natl Cancer Inst 76:45\u201348","journal-title":"J Natl Cancer Inst"},{"key":"0316_CR61","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/jnci\/87.9.645","volume":"87","author":"Rutquist","year":"1995","unstructured":"Rutquist LE, Johansson H (1995) Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. J Natl Cancer Inst 87:645\u2013651","journal-title":"J Natl Cancer Inst"},{"key":"0316_CR62","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/(SICI)1097-0045(20000101)42:1<45::AID-PROS6>3.0.CO;2-W","volume":"42","author":"Shibata","year":"2000","unstructured":"Shibata Y, Ito K, Suzuki K, Nakano K, Fukabori Y, Suzuki R, Kawabe Y, Honma S, Yamanaka H (2000) Changes in the endocrine environment of the human prostate transition zone with aging: simultaneous quantitative analysis of prostatic sex steroids and comparison with human prostatic histological composition. Prostate 42:45\u201355","journal-title":"Prostate"},{"key":"0316_CR63","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/S0039-128X(98)00054-3","volume":"63","author":"Shughrue","year":"1998","unstructured":"Shughrue PJ, Lane MV, Scrimo PJ, Merchenthaler I (1998) Comparative distribution of estrogen receptor-alpha (ER-alpha) and beta (ER-beta) mRNA in the rat pituitary, gonad, and reproductive tract. Steroids 63:498\u2013504","journal-title":"Steroids"},{"key":"0316_CR64","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0303-7207(85)90131-5","volume":"39","author":"Simard","year":"1985","unstructured":"Simard J, Labrie F (1985) Keoxifene shows pure antiestrogenic activity in pituitary gonadotrophs. Mol Cell Endocrinol 39:141\u2013144","journal-title":"Mol Cell Endocrinol"},{"key":"0316_CR65","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0090-4295(93)90352-B","volume":"42","author":"Steiner","year":"1993","unstructured":"Steiner MS (1993) The role of peptide growth factors in the prostate: a review. Urology 42:99\u2013110","journal-title":"Urology"},{"key":"0316_CR66","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0022-5347(01)67516-5","volume":"153","author":"Steiner","year":"1995","unstructured":"Steiner MS (1995) Review of peptide growth factors in benign prostatic hyperplasia and urologic malignancy. J Urol 153:1085\u20131096","journal-title":"J Urol"},{"key":"0316_CR67","unstructured":"Steiner MS, Pound CR, Gingrich JR, Patterson AL, Wake RW, Conrad LW, Kisber RH, McSwain M, Shelton T (2002) Acapodene (GTx-006) reduces high grade prostate intraepithelial neoplasia (HGPIN) in phase II clinical trial. Program and abstracts from the American Society of Clinical Oncology 38th Annual Meeting, 18\u201321 May, Orlando, abstract 719"},{"key":"0316_CR68","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1006\/toxs.1997.2404","volume":"41","author":"Treinen","year":"1998","unstructured":"Treinen KA, Rehm S, Wier PJ (1998) An evaluation of the novel selective estrogen receptor modulator, idoxifene, for effects on reproduction in rats and rabbits. Toxicol Sci 41:199\u2013207","journal-title":"Toxicol Sci"},{"key":"0316_CR69","first-page":"353","volume":"11","author":"Tremblay","year":"1997","unstructured":"Tremblay GB, Tremblay A, Copeland NG, Gilbert DJ, Jenkins NA, Labrie F, Giguere V (1997) Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor beta. Mol Endocrinol 11:353\u2013365","journal-title":"Mol Endocrinol"},{"key":"0316_CR70","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0140-6736(94)92692-1","volume":"343","author":"Van","year":"1994","unstructured":"Van Leeuwen FE, Benraadt J, Coebergh JWW (1994) Risk of endometrial cancer after tamoxifen treatment of breast cancer. Lancet 343:448\u2013452","journal-title":"Lancet"},{"key":"0316_CR71","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0006-291X(05)80067-1","volume":"173","author":"Veldscholte","year":"1990","unstructured":"Veldscholte J, Ris-Stalpers C, Kuiper GG, Jenster G, Berrevoets C, Claassen E, van Rooij HC, Trapman J, Brinkmann AO, Mulder E (1990) A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens. Biochem Biophys Res Commun 173:534\u2013540","journal-title":"Biochem Biophys Res Commun"},{"key":"0316_CR72","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1172\/JCI108353","volume":"57","author":"Walsh","year":"1976","unstructured":"Walsh PC, Wilson JD (1976) The induction of prostatic hypertrophy in the dog with androstanediol. J Clin Invest 57:1093\u20131097","journal-title":"J Clin Invest"},{"key":"0316_CR73","unstructured":"Wang YZ, Hayward SW, Cao M, Young P, Cunha GR (2001) Role of estrogen signaling in prostatic hormonal carcinogenesis. Program abstracts from the American Urological Association Anaheim 2001 Annual Meeting, 2\u20137 June, Anaheim, abstract 543"},{"key":"0316_CR74","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1006\/bbrc.1997.6915","volume":"236","author":"Watanabe","year":"1997","unstructured":"Watanabe T, Inoue S, Ogawa S, Ishii Y, Hiroi H, Ikeda K, Orimo A, Muramatsu M (1997) Agonistic effect of tamoxifen is dependent on cell type, ERE-promoter context, and estrogen receptor subtype: functional difference between estrogen receptors alpha and beta. Biochem Biophys Res Commun 236:140\u2013145","journal-title":"Biochem Biophys Res Commun"},{"key":"0316_CR75","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1093\/carcin\/13.12.2197","volume":"13","author":"White","year":"1992","unstructured":"White IN, De Matteis F, Davies A (1992) Genotoxic potential of tamoxifen and analogues in female Fischer F334\/n rats, DBA\/2 and C57BL\/6 mice and in human MCL-5 cells. Carcinogenesis 13:2197\u20132203","journal-title":"Carcinogenesis"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-002-0316-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00345-002-0316-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-002-0316-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T22:17:13Z","timestamp":1576102633000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00345-002-0316-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,2,14]]},"references-count":75,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,5]]}},"alternative-id":["0316"],"URL":"https:\/\/doi.org\/10.1007\/s00345-002-0316-x","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"value":"0724-4983","type":"print"},{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,2,14]]}}}